Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
The tumor necrosis factor type 1 death receptor (TNFR1) contributes to apoptosis. TNFR1, a subgroup of the TNFR superfamily, contains a cytoplasmic death domain. We recently demonstrated that the TNFR1 cascade is required for amyloid β protein (Aβ)–induced neuronal death. However, the function of TNFR1 in Aβ plaque pathology and amyloid precursor protein (APP) processing in Alzheimer's disease (AD) remains unclear. We report that the deletion of the TNFR1 gene in APP23 transgenic mice (APP23/TNFR1−/−) inhibits Aβ generation and diminishes Aβ plaque formation in the brain. Genetic deletion of TNFR1 leads to reduced β-secretase 1 (BACE1) levels and activity. TNFR1 regulates BACE1 promoter activity via the nuclear factor-κB pathway, and the deletion of TNFR1 in APP23 transgenic mice prevents learning and memory deficits. These findings suggest that TNFR1 not only contributes to neurodegeneration but also that it is involved in APP processing and Aβ plaque formation. Thus, TNFR1 is a novel therapeutic target for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence had linked the inhibition of TNF-α signaling with reduction of both Aβ and tau pathologies in vivo36,37.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 1×
“The receptorinduced multimerization of a Fas-associated death domain protein leads to caspase activation, which causes degradation of specifi c target proteins, ultimately damaging cell integrity (Ashkenazi and Dixit, 1998).”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 1×
“This might be because the APP transgene is controlled by different promoters in APP23 and Tg2576 mice (Irizarry et al., 1997; Sturchler-Pierrat et al., 1997).”
BackgroundSelf-citationFarris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Research works printed but not linked: 2
- 2003, Science., 299, 1014
- 2005, Med. Sci. Monit., 11, BR357
Cited by
Items 301–390 of 390
Neuroinflammation modulates the association of PGRN with cerebral amyloid-β burden
Xu, W., Tan, C., Cao, X., & Tan, L. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.016 · Cited by 11
Mace, K. E., Lussier, M. P., Boulay, G., Terry, J. L., Parfrey, H., Perraud, A., & Riches, D. W. H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22221 · Cited by 10
“Furthermore, TNF-R1 deficient mice have been shown to be resistant to the development of neurodegeneration in an amyloid-dependent model of Alzheimer’s disease (He et al., 2007).”
BackgroundAlmalki, W. H., & Almujri, S. S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155614 · Cited by 9
Zayed, M., Kim, Y., & Jeong, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04273-x · Cited by 11
Effects of diverse Types of Toxoplasma gondii on the outcome of Alzheimer's disease in the rat model
Galeh, T. M., Ghazvini, H., Mohammadi, M., Sarvi, S., Azizi, S., Asgarian‐Omran, H., Hajizadeh, F., & Daryani, A. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105931 · Cited by 11
Liu, L., Fissel, J. A., Tasnim, A., Borzan, J., Gocke, A. R., Calabresi, P. A., & Farah, M. H. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.002 · Cited by 9
Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease
Zheng, F., Dong, T., Chen, Y., Wang, L., & Peng, G. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115021 · Cited by 8
An, F.-M., Xuan, X., Liu, Z., Bian, M., Shen, Q., Quan, Z., Zhang, G., & Wei, C. (2022) · Molecules · doi:10.3390/molecules27155035 · Cited by 8
Pająk, B., Kania, E., & Orzechowski, A. (2015) · BioMed Research International · doi:10.1155/2015/746092 · Cited by 11
“Age-dependent onset of neurodegenerative diseases most likely correlates with agedependent increase of brain cholesterol and DRL secretion [9] as well as age-dependent decline of autophagic activity.”
BackgroundInfluentialHoriuchi, H., Parajuli, B., Kawanokuchi, J., Jin, S., Mizuno, T., Takeuchi, H., & Suzumura, A. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12192 · Cited by 8
Halder, A., Yadav, K., Aggarwal, A., Singhal, N. K., & Sandhir, R. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109714 · Cited by 9
Role of Metalloproteinases in Diabetes-associated Mild Cognitive Impairment
Pereira, V. M., Pradhanang, S., Prather, J. F., & Nair, S. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240517090855 · Cited by 7
Kurmi, S., Doshi, G., & Parab, S. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273377780250505115039 · Cited by 9
Çiftci, H., Aşut, G., Kaya, H., Çakmak, I. B., Yılmaz, M. A., Çöpür, A., Çalcı, E., Oğuz, E. F., Turhan, T., & Göka, E. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.11.006 · Cited by 9
Liao, C., Fang, K., Huang, H.-T., Chang, W.-R., Chuang, C.-C., & Tzeng, S. (2021) · Life · doi:10.3390/life11090961 · Cited by 7
Amyloid Beta, TNFα and FAIM-L; Approaching New Therapeutic Strategies for AD
Carriba, P., & Comella, J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00276 · Cited by 6
Almazán, J. L., Cortes-Flores, E., Ramírez-Olvera, A., Palomero‐Rivero, M., Camacho‐Concha, N., Guerra‐Crespo, M., Prieto, G. A., Pérez‐Martínez, L., & Pedraza‐Alva, G. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.019 · Cited by 6
Shi, Y., Gao, F., Yang, X., Liu, D., Han, Q., Liu, Z., Zhu, H., & Shen, Y. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200204 · Cited by 6
Self-citationGiudici, K. V., Guyonnet, S., Morley, J. E., Nguyen, A. D., Aggarwal, G., Parini, A., Li, Y., Bateman, R. J., Vellas, B. J., Barreto, P. D. S., et al. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac015 · Cited by 7
The Role of Inflammation in Alzheimer’s Disease
Müller, N., Krause, D., Schwarz, M., Weidinger, E., & Reinisch, V. M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_15 · Cited by 5
Oxidative Stress in Neurodegenerative Diseases
Alami, M., Fülöp, T., Boumezough, K., Khalil, A., Zerif, E., & Berrougui, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-69962-7_4 · Cited by 8
Neuropsychological Parameters as Potential Biomarkers for Alzheimer’s Disease
Wu, J., Yu, Y., & Yang, J. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-012-0007-4 · Cited by 5
Qin, S., Fang, J., He, X., Yu, G., Yi, F., & Zhu, G. (2024) · Biology · doi:10.3390/biology13070544 · Cited by 6
“Additionally, mice lacking TNF-α in hybrid models with AD transgenic mice show reduced A β aggregation and diminished glial cell activity, leading to cognitive function restoration [20].”
BackgroundÇELİK, H., Çelik, O., Aydın, Ş., Küçükler, S., Çomaklı, S., Topal, A., Akay, R., Gönüllü, S., Yıldız, M. O., Alım, B., et al. (2026) · Gene · doi:10.1016/j.gene.2026.150014 · Cited by 4
Paidlewar, M., Kumari, S., Dhapola, R., Sharma, P., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.053 · Cited by 6
The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review
Corcoran, E., Kettlety, M., Mogul, U., Azah, J. N., & Cork, S. C. (2026) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2026.104091 · Cited by 6
Chaigneau, T., Sha, S., Roux, C. M., Aïd, S., Faucher, A., Chantran, Y., Dorothée, G., & Krantic, S. M. (2025) · Glia · doi:10.1002/glia.70029 · Cited by 3
“…in cortex precede hippocampal changes due to the earlier onset of amyloidosis and microgliosis in the cortex; (iii) in contrast to tnfr1 (He et al. 2007), tnfr2 has been demonstrated to play a protective role in AD-like amyloidosis and microgliosis (Jiang et al. 2014), it could be…”
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C. A., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem2048oia23 · Cited by 3
Self-citationA Novel Missense Variant in SORBS2 Is Causative With Familial Alzheimer's Disease
Wang, Q., Wang, S., Cao, S., Wang, Q., Wei, Y., Li, Y., Wang, Y., Li, Y., Qin, W., Quan, M., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70256 · Cited by 3
Ramírez-Olvera, A., Almazán, J. L., Pérez‐Martínez, L., & Pedraza‐Alva, G. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04740-8 · Cited by 3
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 11
Death receptor takes centre stage
Whalley, K. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2242 · Cited by 2
Underlying biological substrates associated with cognitive dysfunction in major depressive disorder
(2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.012 · Cited by 2
Neuroinflammation in depression
Dobos, N. (2014) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Qi, L., Lin, L., Zheng, J., Liu, X., Liu, X., Chen, Z., & Liu, L. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf265 · Cited by 1
Garrahy, J. P. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251404970 · Cited by 2
Hamdan, A. M. E., Abu‐Elfotuh, K., Alshaman, R., Salem, H. A., Hamdan, A. M., Alaisayi, K. H. A., Alharthi, S. A. S., Aljehani, R. F., Alsharif, F. I. M., Abalhassan, A. K. M., et al. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110309 · Cited by 1
Udaiyappan, J. P., Balakrishnan, R., Tamilarasan, M. M., Balasubramanian, B., & Abass, K. S. (2026) · Inflammation · doi:10.1007/s10753-026-02492-9 · Cited by 3
Apoptosis in Neurodegenerative Diseases
Liang, Q., & Zhang, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_21 · Cited by 1
Insulin resistance, diabetes, and metabolic syndrome
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00002-x · Cited by 1
New Perspectives for the Treatment of Alzheimer’s Disease~!2008-10-07~!2008-10-30~!2008-11-26~!
Galimberti, D., & Scarpini, E. A. (2008) · The Open Geriatric Medicine Journal · doi:10.2174/1874827900801010033 · Cited by 2
Microglia in the Alzheimers brain: a help or a hindrance?
Vollert, C. T., & Eriksen, J. L. (2014) · AIMS neuroscience · doi:10.3934/neuroscience.2014.3.210
Darlington, D. (2014) · Digital Commons - University of South Florida (University of South Florida)
New Perspectives for the Treatment of Alzheimer's Disease
Galimberti, D., & Scarpini, E. A. (2008) · The Open Geriatric Medicine Journal
BACE1 Inhibitors: Attractive Therapeutics for Alzheimer’s Disease
Decourt, B., Macias, M. P., Sabbagh, M., & Adem, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50010-6
Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
Dionísio, P. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Using TUDCA to treat Alzheimer's disease after pathology onset in APP/PS1 mice
Farmácia, F. D. (2014)
Inflammation and cognition in major depressive disorder
Baune, B. T. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.013
Activation of survival pathways triggered by death receptors in the nervous system
Fernández, F. M. (2013) · TDX (Tesis Doctorals en Xarxa)
Inflammatory pathology in neurodegenerative dementias
Niedermayer, G. (2014)
Therapeutic strategies for neurodegenerative disorders
Dong, Y. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology)
An insight into lymphotoxin and TNF-α role in neuroinflammatory neurodegenerative diseases
Hernández, R. F. (2017)
Ralph, S., & Clark, I. (2015) · Healthy Aging Research · doi:10.12715/har.2015.4.14
Salemi, M., Soma, P. F., Bosco, P., Vicari, E. S. D., Castiglione, R., & Calogero, A. E. (2013) · Human Cell · doi:10.1007/s13577-013-0072-9
Rommy von Bernhardi, M., Flores, B., & Nakanishi, H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_13
Neuroinflammation: friend or foe in Alzheimer's disease?
Ortí-Casañ, N. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.274713267
Kwon, H. J., Santhosh, D., & Huang, Z. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.24.550398
Hao, W., Luo, Q., Tomic, I., Quan, W., Hartmann, T., Menger, M. D., Fassbender, K. C., & Liu, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570400
Neuro-inflammatory Responses in Alzheimer’s v/s Parkinson’s Diseases
Amrutha, K., & Singh, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010005
Liu, W., Li, W., Liu, Z., Li, Y., Wang, X., Guo, M., Wang, S., Wang, S., & Jia, J. X. (2024) · Figshare · doi:10.6084/m9.figshare.25792757
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694843
Liu, W., Li, W., Liu, Z., Li, Y., Wang, X., Guo, M., Wang, S., Wang, S., & Jia, J. X. (2024) · Figshare · doi:10.6084/m9.figshare.25792881
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694840
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694825
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694849
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694861
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694837
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694834
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694846
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694858
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694852
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694831
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694828
Jagadeesan, N., Roules, G. C., Chandrashekar, D. V., Yang, J., Kolluru, S., & Sumbria, R. K. (2024) · Figshare · doi:10.6084/m9.figshare.26694855
Cytokine Alterations and Targeting in Neurodegeneration: Role of Nanomaterials
Naeem, A., & Raza, S. S. (2026) · Springer eBooks · doi:10.1007/978-981-95-5088-3_5
Zhang, Y., Sun, L., Zhao, Y., Zhang, Z., Chen, H., Zhao, M., Miao, Z., Wang, W., Xu, X., & Initiative, A. D. N. (2026) · BMC Medicine · doi:10.1186/s12916-026-04623-3
Li, D., Li, Y., Wen, L., Chen, Z., Gao, F., Shen, Y., & Wang, Q. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01593-7
Self-citationTaha, M. M. E., Abdelwahab, S. I., Alshahrani, S., Jali, A. M., Qadri, M. M., Alarifi, A., & Al-Shamsi, H. O. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05545-w
“Alzheimer’s disease occupies the most intense and central hotspot, surrounded by closely connected themes such as neuroinflammation, apoptosis, oxidative stress, β-amyloid, tau, and cytokines (He et al. 2007; Khodamoradi et al. 2025).”
Research advances on acute kidney injury and brain dysfunction
Li, M. M., Liao, X., & Ran, J. (2026) · Frontiers in Nephrology · doi:10.3389/fneph.2026.1867473
Poffenberger, C. N., Taylor, M. M., Larson, K., Mufson, E. J., & Dixon, K. J. (2026) · Journal of Neurotrauma · doi:10.1177/08977151261469044
Update on sex-specific microglia contribution to early synaptic dysfunction in Alzheimer’s disease
Roux, C. M., & Krantic, S. M. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1905780
RNA interference in neurological disorders: Silencing harmful immune responses
Farhan, M., Islam, M. S., Srivastava, Y., Singh, J., Khan, H., & Zhang, Q. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44631-3.00013-5
Delgado, M., Roja, A., Pareek, O., Penman, S. L., Smith, D., & Thanos, P. K. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2752371
TRIPTOLIDE IS A POTENTIAL THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
Allsbrook, M. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/94wv-p926
Metadata
- Authors
- He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y.
- Affiliations
- Banner Sun Health Research Institute (US)
- 1Haldeman Laboratory of Molecular and Cellular Neurobiology
- Brigham and Women's Hospital (US)
- Novartis (Switzerland) (CH)
- Corresponding author
- Shen, Yong
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2007-08-27
- Volume
- 178
- Issue
- 5
- Pages
- 829-841
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2064547
- OpenAlex
- W2096277075
- Cited by
- 390
- References
- 76
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 27 · 2023: 11 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 17 · 2016: 15 · 2015: 30 · 2014: 35 · 2013: 24 · 2012: 18
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG025888, AG025888)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tumor necrosis factor receptor 1, Alzheimer's disease, amyloid-beta production, amyloid plaques, APP processing, beta-secretase 1, BACE1, NF-κB signaling, APP23 transgenic mice, learning and memory impairment, neurodegeneration, death receptor signaling
- MeSH terms
- Alzheimer Disease, Animals, Behavior, Animal, Disease Models, Animal, Gene Expression Regulation, Humans, Insulysin, Learning, Memory Disorders, Mice, Transgenic, Neurons, Promoter Regions, Genetic, Tumor Necrosis Factor-alpha, Neprilysin, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, NF-kappa B, Cerebral Amyloid Angiopathy, Gene Deletion, Microglia, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Mice, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.